CrossRef Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes Isabel Krug, An Binh Dang, Jade Portingale, Yakun Li, Ying Qing Won Nutrients.2025
With over 10 million users and growing, the service is designed to help patients decide when testing or in-person care is necessary
a 2025 review concluded that GLP-1R agonists reduce alcohol intake, lower the motivation to drink, and prevent relapse drinking in preclinical models [16]
Severe or worsening symptoms warrant prompt medical evaluation, particularly if there is tenderness over the gallbladder or abnormal vital signs
The mechanism works independently of weight loss, meaning patients experience some inflammatory relief even in early treatment weeks before substantial fat loss occurs
Phase 2 data published in the New England Journal of Medicine demonstrated substantial weight reduction in some participants exceeding 20% of body weight over 48 weeks alongside improvements in cardiometabolic markers